Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Van Cutsem, Eric; Moiseyenko, Vladimir; Tjulandin, Sergei; Majlis, Alejandro; Constenla, Manuel; Boni, C.; Rodrigues, Adriano; Fodor, M; Chao, Yee; К Возный, Э; Risse, Marie-Laure; A. Ajani, Jaffer

doi:10.1200/jco.2006.06.8429

Public

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Published in Journal of Clinical Oncology • Oct 30, 2006

Authors:

Eric Van Cutsem

Vladimir Moiseyenko

Sergei Tjulandin

Abstract

PURPOSE: In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorouracil (DCF) over docetaxel and cisplatin for comparison against cisplatin and fluorouracil (CF; reference regimen) in the pha...

Subject

Docetaxel

Medicine

Fluorouracil

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!